{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:44:46Z","timestamp":1789767886948,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872524"],"award-info":[{"award-number":["81872524"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073431"],"award-info":[{"award-number":["82073431"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012020"],"award-info":[{"award-number":["2022A1515012020"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.intimp.2022.109197","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T19:02:03Z","timestamp":1662058923000},"page":"109197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1\u03b2 in systemic lupus erythematosus"],"prefix":"10.1016","volume":"112","author":[{"given":"Zhenrui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqiu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109197_b0005","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2022.109197_b0010","article-title":"Vascular disease in systemic lupus erythematosus","volume":"2012","author":"Pyrpasopoulou","year":"2012","journal-title":"Autoimmune Dis."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0015","first-page":"216","article-title":"Cutaneous lupus erythematosus: clinico-pathologic correlation","volume":"153","author":"Filotico","year":"2018","journal-title":"G. Ital. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.md.0000216817.35937.70","article-title":"Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients","volume":"85","author":"Ramos-Casals","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.intimp.2022.109197_b0025","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0961203317739134","article-title":"Cutaneous vasculitis in systemic lupus erythematosus patients: potential key players and implications","volume":"27","author":"Gheita","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2022.109197_b0030","doi-asserted-by":"crossref","unstructured":"R. Kallas, D. Goldman, M.A. Petri, Cutaneous vasculitis in SLE. Lupus Sci. Med. 7(1) (2020).","DOI":"10.1136\/lupus-2020-000411"},{"issue":"10","key":"10.1016\/j.intimp.2022.109197_b0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109197_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000418","article-title":"Lupus serum induces inflammatory interaction with neutrophils in human glomerular endothelial cells","volume":"7","author":"Russell","year":"2020","journal-title":"Lupus Sci. Med."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2022.109197_b0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fimmu.2015.00184","article-title":"Autoantibodies in systemic vasculitis","volume":"6","author":"Silva de Souza","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109197_b0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/art.38891","article-title":"Association of anti-acidic ribosomal protein P0 and anti-galectin 3 antibodies with the development of skin lesions in systemic lupus erythematosus","volume":"67","author":"Shi","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0060","first-page":"109","article-title":"IL-1 beta-deficient mice are resistant to induction of experimental SLE","volume":"17","author":"Voronov","year":"2006","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.intimp.2022.109197_b0065","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3389\/fimmu.2018.01250","article-title":"Analysis of Serum Interleukin (IL)-1beta and IL-18 in Systemic Lupus Erythematosus","volume":"9","author":"Mende","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109197_b0070","doi-asserted-by":"crossref","unstructured":"N. Ruchakorn, P. Ngamjanyaporn, T. Suangtamai, T. Kafaksom, C. Polpanumas, V. Petpisit, T. Pisitkun, P. Pisitkun, Performance of cytokine models in predicting SLE activity, Arthritis Res. Ther. 21(1) (2019) 287.","DOI":"10.1186\/s13075-019-2029-1"},{"issue":"5","key":"10.1016\/j.intimp.2022.109197_b0075","first-page":"411","article-title":"Serum and urinary cytokine levels of SLE patients","volume":"67","author":"Brugos","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.intimp.2022.109197_b0080","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/385297","article-title":"Effect of proinflammatory cytokines (IL-6, TNF-alpha, and IL-1beta) on clinical manifestations in Indian SLE patients","volume":"2014","author":"Umare","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"7","key":"10.1016\/j.intimp.2022.109197_b0085","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","article-title":"NLRP3: A promising therapeutic target for autoimmune diseases","volume":"17","author":"Shen","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2022.109197_b0090","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.40155","article-title":"Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis","volume":"69","author":"Fu","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109197_b0095","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/art.38174","article-title":"P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3\/ASC\/caspase 1 pathway","volume":"65","author":"Zhao","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.intimp.2022.109197_b0100","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/art.38993","article-title":"Lupus nephritis: glycogen synthase kinase 3beta promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice","volume":"67","author":"Zhao","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2022.109197_b0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11926-014-0440-9","article-title":"Vasculitis in systemic lupus erythematosus","volume":"16, (9)","author":"Barile-Fabris","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.intimp.2022.109197_b0110","doi-asserted-by":"crossref","unstructured":"M.C. Hochberg, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum. 40(9) (1997) 1725.","DOI":"10.1002\/art.1780400928"},{"issue":"6","key":"10.1016\/j.intimp.2022.109197_b0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2022.109197_b0120","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00395-008-0733-0","article-title":"The role of inflammatory cytokines in endothelial dysfunction","volume":"103","author":"Zhang","year":"2008","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.intimp.2022.109197_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases","volume":"130","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2022.109197_b0130","doi-asserted-by":"crossref","unstructured":"Y. Yang, H. Wang, M. Kouadir, H. Song, F. Shi, Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors, Cell Death Dis. 10(2) (2019) 128.","DOI":"10.1038\/s41419-019-1413-8"},{"key":"10.1016\/j.intimp.2022.109197_b0135","doi-asserted-by":"crossref","unstructured":"S. Sciacchitano, L. Lavra, A. Morgante, A. Ulivieri, F. Magi, G.P. De Francesco, C. Bellotti, L.B. Salehi, A. Ricci, Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z, Int. J. Mol. Sci. 19(2) (2018).","DOI":"10.3390\/ijms19020379"},{"key":"10.1016\/j.intimp.2022.109197_b0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12014-017-9146-0","article-title":"A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus","volume":"14","author":"Nielsen","year":"2017","journal-title":"Clin. Proteomics"},{"issue":"3","key":"10.1016\/j.intimp.2022.109197_b0145","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12016-017-8627-2","article-title":"The Cutaneous Spectrum of Lupus Erythematosus","volume":"53","author":"Ribero","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109197_b0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrneph.2017.85","article-title":"Redefining lupus nephritis: clinical implications of pathophysiologic subtypes","volume":"13","author":"Yu","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-0034-1371537","article-title":"Pulmonary manifestations of systemic lupus erythematosus","volume":"35","author":"Mittoo","year":"2014","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109197_b0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/BOR.0000000000000347","article-title":"Vasculitis in the autoinflammatory diseases","volume":"29","author":"Peleg","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.intimp.2022.109197_b0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11926-016-0584-x","article-title":"Connective Tissue Disorder-Associated Vasculitis","volume":"18, (6)","author":"Sharma","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.autrev.2016.12.012","article-title":"Anti-endothelial cell antibodies in vasculitis: A systematic review","volume":"16","author":"Legendre","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109197_b0180","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.autrev.2016.03.007","article-title":"Pathogenesis of ANCA-associated vasculitis: An update","volume":"15","author":"Jarrot","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2022.109197_b0185","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3389\/fimmu.2019.01426","article-title":"IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis","volume":"10","author":"Fahey","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0190","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cyto.2015.01.031","article-title":"The role of cytokines in the pathogenesis of cutaneous lupus erythematosus","volume":"73","author":"Robinson","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2022.109197_b0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2015.02.002","article-title":"Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab","volume":"45","author":"Berti","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2022.109197_b0200","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.4049\/jimmunol.1101737","article-title":"Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models","volume":"189","author":"McGeough","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109197_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106985","article-title":"IL-6 promotes collagen-induced arthritis by activating the NLRP3 inflammasome through the cathepsin B\/S100A9-mediated pathway","volume":"88","author":"Wang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109197_b0210","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.4049\/jimmunol.0802484","article-title":"IL-10 is a negative regulatory factor of CAWS-vasculitis in CBA\/J mice as assessed by comparison with Bruton's tyrosine kinase-deficient CBA\/N mice","volume":"183","author":"Miura","year":"2009","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109197_b0215","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.4049\/jimmunol.1203182","article-title":"Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction","volume":"190","author":"Xu","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2022.109197_b0220","doi-asserted-by":"crossref","unstructured":"K. Mahonen, A. Hau, V. Bondet, D. Duffy, K.K. Eklund, J. Panelius, A. Ranki, Activation of NLRP3 Inflammasome in the Skin of Patients with Systemic and Cutaneous Lupus Erythematosus, Acta Derm. Venereol. 102 (2022) adv00708.","DOI":"10.2340\/actadv.v102.2293"},{"issue":"10","key":"10.1016\/j.intimp.2022.109197_b0225","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/0961203317692419","article-title":"Prognostic significance of renal vascular pathology in lupus nephritis","volume":"26","author":"Mejia-Vilet","year":"2017","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.intimp.2022.109197_b0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/0886022X.2019.1702057","article-title":"Renal microvascular lesions in lupus nephritis","volume":"42","author":"Ding","year":"2020","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.intimp.2022.109197_b0235","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.2004.025858","article-title":"Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis","volume":"64","author":"Ostendorf","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2022.109197_b0240","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1191\/0961203304lu1047cr","article-title":"IL-1RA in refractory systemic lupus erythematosus","volume":"13","author":"Moosig","year":"2004","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.intimp.2022.109197_b0245","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2013.04.008","article-title":"Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study","volume":"132","author":"Krause","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109197_b0250","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/03009740600938647","article-title":"Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra","volume":"36","author":"Botsios","year":"2007","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.intimp.2022.109197_b0255","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3389\/fphar.2018.01157","article-title":"Anakinra Therapy for Non-cancer Inflammatory Diseases","volume":"9","author":"Cavalli","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109197_b0260","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.ki.5000042","article-title":"Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta","volume":"69","author":"Yung","year":"2006","journal-title":"Kidney Int."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922006816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:40:55Z","timestamp":1761586855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922006816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":52,"alternative-id":["S1567576922006816"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109197","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1\u03b2 in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109197"}}